BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, Branch DW, Goodship T, Fremeaux-Bacchi V, Atkinson JP. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8:e1001013. [PMID: 21445332 DOI: 10.1371/journal.pmed.1001013] [Cited by in Crossref: 195] [Cited by in F6Publishing: 174] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Ueda M, Sato Y, Horie A, Tani H, Miyazaki Y, Okunomiya A, Matsumoto H, Hamanishi J, Kondoh E, Mandai M. Endovascular trophoblast expresses CD59 to evade complement-dependent cytotoxicity. Mol Cell Endocrinol 2019;490:57-67. [PMID: 30981734 DOI: 10.1016/j.mce.2019.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Johnson SA, Wong EK, Taylor CM. Making sense of the spectrum of glomerular disease associated with complement dysregulation. Pediatr Nephrol 2014;29:1883-94. [PMID: 23852337 DOI: 10.1007/s00467-013-2559-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Elabd H, Elkholi M, Steinberg L, Acharya A. Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia/HELLP syndrome. BMJ Case Rep 2019;12:e228709. [PMID: 31492725 DOI: 10.1136/bcr-2018-228709] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
4 Rao S, Jim B. Acute Kidney Injury in Pregnancy: The Changing Landscape for the 21st Century. Kidney Int Rep 2018;3:247-57. [PMID: 29725629 DOI: 10.1016/j.ekir.2018.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
5 Salmon JE, Mineo C, Giles I, Chamley LW, Meroni PL, Abrahams VM. Mechanisms of Antiphospholipid Antibody-Mediated Pregnancy Morbidity. In: Erkan D, Lockshin MD, editors. Antiphospholipid Syndrome. Cham: Springer International Publishing; 2017. pp. 117-43. [DOI: 10.1007/978-3-319-55442-6_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Antiphospholipid syndrome. Nat Rev Dis Primers 2018;4:17103. [PMID: 29321641 DOI: 10.1038/nrdp.2017.103] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 21.5] [Reference Citation Analysis]
7 Fakhouri F, Frémeaux-Bacchi V. Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies. Clin J Am Soc Nephrol 2019;14:1682-3. [PMID: 31811084 DOI: 10.2215/CJN.12111019] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Bitsadze V, Bouvier S, Khizroeva J, Cochery-Nouvellon É, Mercier É, Perez-Martin A, Makatsariya A, Gris JC. Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome. Thromb Res 2021;203:101-9. [PMID: 33989981 DOI: 10.1016/j.thromres.2021.04.021] [Reference Citation Analysis]
9 Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Review of Clinical Immunology 2014;8:439-53. [DOI: 10.1586/eci.12.36] [Cited by in Crossref: 59] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
10 Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A. A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity. Int J Mol Sci 2020;21:E3886. [PMID: 32485958 DOI: 10.3390/ijms21113886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Gibbins KJ, Ware Branch D. Pre-eclampsia as a manifestation of antiphospholipid syndrome: assessing the current status. Lupus 2014;23:1229-31. [PMID: 25228712 DOI: 10.1177/0961203314531347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Regal JF, Strehlke ME, Peterson JM, Wing CR, Parker JE, Nieto NF, Bemis LT, Gilbert JS, Fleming SD. Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. Mol Immunol 2016;78:38-47. [PMID: 27588825 DOI: 10.1016/j.molimm.2016.08.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
13 Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184-192. [PMID: 25391611 DOI: 10.1007/s12026-014-8577-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
14 Banadakoppa M, Balakrishnan M, Yallampalli C. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells. Am J Reprod Immunol 2018;80:e13033. [PMID: 30099798 DOI: 10.1111/aji.13033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 Pillay Y, Moodley J, Naicker T. The role of the complement system in HIV infection and preeclampsia. Inflamm Res 2019;68:459-69. [PMID: 31028431 DOI: 10.1007/s00011-019-01240-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ancuța E, Zamfir R, Martinescu G, Crauciuc DV, Ancuța C. The Complement System, T Cell Response, and Cytokine Shift in Normotensive versus Pre-Eclamptic and Lupus Pregnancy. J Clin Med 2021;10:5722. [PMID: 34945017 DOI: 10.3390/jcm10245722] [Reference Citation Analysis]
17 Lashley LE, Buurma A, Swings GM, Eikmans M, Anholts JD, Bakker JA, Claas FH. Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology? J Reprod Immunol 2015;109:17-23. [PMID: 25863695 DOI: 10.1016/j.jri.2015.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
18 Bouvier S, Cochery-nouvellon É, Lavigne-lissalde G, Mercier É, Marchetti T, Balducchi J, Marès P, Gris J. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 2014;123:404-13. [DOI: 10.1182/blood-2013-08-522623] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]
19 von Auer C, von Krogh A, Kremer Hovinga JA, Lämmle B. Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy. Thrombosis Research 2015;135:S30-3. [DOI: 10.1016/s0049-3848(15)50437-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 3.4] [Reference Citation Analysis]
20 Van Laecke S, Nagler EV, Vanholder R. Thrombotic microangiopathy: a role for magnesium? Thromb Haemost 2012;107:399-408. [PMID: 22274299 DOI: 10.1160/TH11-08-0593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Vaught AJ, Gavriilaki E, Hueppchen N, Blakemore K, Yuan X, Seifert SM, York S, Brodsky RA. Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome. Exp Hematol 2016;44:390-8. [PMID: 26921648 DOI: 10.1016/j.exphem.2016.01.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 9.5] [Reference Citation Analysis]
22 Tsai HM. Atypical Hemolytic Uremic Syndrome: Beyond Hemolysis and Uremia. Am J Med 2019;132:161-7. [PMID: 30145224 DOI: 10.1016/j.amjmed.2018.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
23 Collier AY, Smith LA, Karumanchi SA. Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy. Hum Immunol 2021;82:362-70. [PMID: 33551128 DOI: 10.1016/j.humimm.2021.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012;8:643-657. [PMID: 23026949 DOI: 10.1038/nrneph.2012.214] [Cited by in Crossref: 349] [Cited by in F6Publishing: 291] [Article Influence: 34.9] [Reference Citation Analysis]
25 Sarode R, Bandarenko N, Brecher ME, Kiss JE, Marques MB, Szczepiorkowski ZM, Winters JL. Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apheresis 2014;29:148-67. [DOI: 10.1002/jca.21302] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
26 Vaught AJ, Braunstein EM, Jasem J, Yuan X, Makhlin I, Eloundou S, Baines AC, Merrill SA, Chaturvedi S, Blakemore K, Sperati CJ, Brodsky RA. Germline mutations in the alternative pathway of complement predispose to HELLP syndrome. JCI Insight 2018;3:99128. [PMID: 29563339 DOI: 10.1172/jci.insight.99128] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
27 Gysler SM, Mulla MJ, Guerra M, Brosens JJ, Salmon JE, Chamley LW, Abrahams VM. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. Mol Hum Reprod 2016;22:465-74. [PMID: 27029214 DOI: 10.1093/molehr/gaw027] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
28 Mohlin FC, Mercier E, Fremeaux-Bacchi V, Liszewski MK, Atkinson JP, Gris JC, Blom AM. Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss. Eur J Immunol 2013;43:1617-29. [PMID: 23508668 DOI: 10.1002/eji.201243196] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
29 Liszewski MK, Atkinson JP. Complement regulators in human disease: lessons from modern genetics. J Intern Med 2015;277:294-305. [PMID: 25495259 DOI: 10.1111/joim.12338] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
30 Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy 2012;2012:374047. [PMID: 22175023 DOI: 10.1155/2012/374047] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
31 Penning M, Chua JS, van Kooten C, Zandbergen M, Buurma A, Schutte J, Bruijn JA, Khankin EV, Bloemenkamp K, Karumanchi SA, Baelde H. Classical Complement Pathway Activation in the Kidneys of Women With Preeclampsia. Hypertension 2015;66:117-25. [PMID: 25941343 DOI: 10.1161/HYPERTENSIONAHA.115.05484] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
32 Shen YM. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome. Thromb J 2016;14:19. [PMID: 27766045 DOI: 10.1186/s12959-016-0114-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
33 Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood 2014;123:1674-80. [PMID: 24398329 DOI: 10.1182/blood-2013-11-538900] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
34 Liszewski MK, Atkinson JP. Complement regulator CD46: genetic variants and disease associations. Hum Genomics 2015;9:7. [PMID: 26054645 DOI: 10.1186/s40246-015-0029-z] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
35 Levine AB, Lockshin MD. Antiphospholipid Syndrome. In: Sammaritano LR, Bermas BL, editors. Contraception and Pregnancy in Patients with Rheumatic Disease. New York: Springer; 2014. pp. 109-37. [DOI: 10.1007/978-1-4939-0673-4_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
36 Burwick RM, Fichorova RN, Dawood HY, Yamamoto HS, Feinberg BB. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension 2013;62:1040-5. [PMID: 24060886 DOI: 10.1161/HYPERTENSIONAHA.113.01420] [Cited by in Crossref: 69] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
37 Lokki AI, Aalto-Viljakainen T, Meri S, Laivuori H; FINNPEC. Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies. PLoS One 2015;10:e0117840. [PMID: 25710174 DOI: 10.1371/journal.pone.0117840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
38 Yelnik CM, Miranda S, Mékinian A, Lazaro E, Quéméneur T, Provot F, Frimat M, Morell-dubois S, Le Guern V, Hachulla E, Costedoat-chalumeau N, Lambert M. Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab. Blood 2020;136:2473-7. [DOI: 10.1182/blood.2020007499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Lu AB, Lazarus B, Rolnik DL, Palmer KR. Pregnancy Prolongation After Eculizumab Use in Early-Onset Preeclampsia. Obstetrics & Gynecology 2019;134:1215-8. [DOI: 10.1097/aog.0000000000003570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
40 Giles I, Cohen H, Ioannou Y. Pathogenesis of Antiphospholipid Antibody Syndrome. Dubois' Lupus Erythematosus and Related Syndromes. Elsevier; 2019. pp. 324-37. [DOI: 10.1016/b978-0-323-47927-1.00024-4] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A, Levy RA, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Willis R, Lockshin MD. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev. 2014;13:685-696. [PMID: 24468415 DOI: 10.1016/j.autrev.2014.01.053] [Cited by in Crossref: 230] [Cited by in F6Publishing: 182] [Article Influence: 28.8] [Reference Citation Analysis]
42 Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012;8:622-33. [PMID: 22986360 DOI: 10.1038/nrneph.2012.195] [Cited by in Crossref: 247] [Cited by in F6Publishing: 218] [Article Influence: 24.7] [Reference Citation Analysis]
43 de Jesus GR, Mendoza-Pinto C, de Jesus NR, Dos Santos FC, Klumb EM, Carrasco MG, Levy RA. Understanding and Managing Pregnancy in Patients with Lupus. Autoimmune Dis 2015;2015:943490. [PMID: 26246905 DOI: 10.1155/2015/943490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
44 Rosove MH. Thrombotic microangiopathies. Seminars in Arthritis and Rheumatism 2014;43:797-805. [DOI: 10.1016/j.semarthrit.2013.11.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
45 Samarkos M, Mylona E, Kapsimali V. The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity. Semin Arthritis Rheum 2012;42:66-9. [PMID: 22405029 DOI: 10.1016/j.semarthrit.2012.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
46 Song D, Yu X, Wang F, Xu B, He Y, Chen Q, Wang S, Yu F, Song W, Zhao M. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement. Am J Reprod Immunol 2015;74:345-56. [DOI: 10.1111/aji.12404] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
47 Banadakoppa M, Balakrishnan M, Yallampalli C. Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype. Sci Rep 2020;10:4811. [PMID: 32179765 DOI: 10.1038/s41598-020-60539-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Tsai H, Kuo E. From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome. Obstetrics & Gynecology 2016;127:907-10. [DOI: 10.1097/aog.0000000000001340] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
49 Brocklebank V, Wood KM, Kavanagh D. Thrombotic Microangiopathy and the Kidney. Clin J Am Soc Nephrol. 2018;13:300-317. [PMID: 29042465 DOI: 10.2215/cjn.00620117] [Cited by in Crossref: 103] [Cited by in F6Publishing: 57] [Article Influence: 20.6] [Reference Citation Analysis]
50 Yousefzadeh Y, Soltani-Zangbar MS, Hemmatzadeh M, Shomali N, Mahmoodpoor A, Ahmadian Heris J, Yousefi M. Fetomaternal Immune Tolerance: Crucial Mechanisms of Tolerance for Successful Pregnancy in Humans. Immunol Invest 2021;:1-18. [PMID: 33830854 DOI: 10.1080/08820139.2021.1909061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Adamski J. Thrombotic microangiopathy and indications for therapeutic plasma exchange. Hematology 2014;2014:444-9. [DOI: 10.1182/asheducation-2014.1.444] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
52 Kingdom JC, Drewlo S. Is heparin a placental anticoagulant in high-risk pregnancies? Blood 2011;118:4780-8. [PMID: 21868576 DOI: 10.1182/blood-2011-07-319749] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
53 Brocklebank V, Kavanagh D. Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. Clin Kidney J 2017;10:600-24. [PMID: 28980670 DOI: 10.1093/ckj/sfx081] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
54 Saleh M, Sjöwall C, Strevens H, Jönsen A, Bengtsson AA, Compagno M. Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus: An Observational Study from a Single Centre in Sweden. J Clin Med 2020;9:E2598. [PMID: 32796552 DOI: 10.3390/jcm9082598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Andrade D, Tektonidou M. Emerging Therapies in Antiphospholipid Syndrome. Curr Rheumatol Rep 2016;18:22. [PMID: 26995745 DOI: 10.1007/s11926-016-0566-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
56 Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol 2015;67:56-70. [PMID: 25802092 DOI: 10.1016/j.molimm.2015.02.030] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 11.9] [Reference Citation Analysis]
57 Scully M. How to evaluate and treat the spectrum of TMA syndromes in pregnancy. Hematology Am Soc Hematol Educ Program 2021;2021:545-51. [PMID: 34889427 DOI: 10.1182/hematology.2021000290] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Vaught AJ. Critical Care for the Obstetrician and Gynecologist: Obstetric Hemorrhage and Disseminated Intravascular Coagulopathy. Obstet Gynecol Clin North Am 2016;43:611-22. [PMID: 27816150 DOI: 10.1016/j.ogc.2016.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
59 Scambi C, Ugolini S, Tonello M, Bortolami O, De Franceschi L, Castagna A, Lotti V, Corbella M, Raffaelli R, Caramaschi P, Mattia E, Biasi D, Ruffatti A. Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome. Am J Reprod Immunol 2019;82. [DOI: 10.1111/aji.13185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Bertram P, Akk AM, Zhou HF, Mitchell LM, Pham CT, Hourcade DE. Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis. Monoclon Antib Immunodiagn Immunother 2015;34:1-6. [PMID: 25723276 DOI: 10.1089/mab.2014.0066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
61 Regal JF, Burwick RM, Fleming SD. The Complement System and Preeclampsia. Curr Hypertens Rep 2017;19:87. [PMID: 29046976 DOI: 10.1007/s11906-017-0784-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
62 Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2013;27:435-47. [PMID: 24238698 DOI: 10.1016/j.berh.2013.07.005] [Cited by in Crossref: 89] [Cited by in F6Publishing: 66] [Article Influence: 11.1] [Reference Citation Analysis]
63 Román E, Mendizábal S, Jarque I, de la Rubia J, Sempere A, Morales E, Praga M, Ávila A, Górriz JL. Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option. Nefrologia 2017;37:478-91. [PMID: 28946961 DOI: 10.1016/j.nefro.2017.01.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
64 Java A, Atkinson J, Salmon J. Defective complement inhibitory function predisposes to renal disease. Annu Rev Med 2013;64:307-24. [PMID: 23121180 DOI: 10.1146/annurev-med-072211-110606] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
65 Varghese S, Crocker I, Bruce IN, Tower C. Systemic lupus erythematosus, regulatory T cells and pregnancy. Expert Review of Clinical Immunology 2014;7:635-48. [DOI: 10.1586/eci.11.59] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
66 Abrahams VM, Chamley LW, Salmon JE. Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation. Arthritis Rheumatol 2017;69:1710-21. [PMID: 28445926 DOI: 10.1002/art.40136] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
67 Meiri H, Osol G, Cetin I, Gizurarson S, Huppertz B. Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function. Comput Struct Biotechnol J 2017;15:433-46. [PMID: 29034064 DOI: 10.1016/j.csbj.2017.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
68 Timmermans SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, Damoiseaux JGMC, Morelle J, van Paassen P. The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives. Br J Haematol 2020;190:442-9. [PMID: 32342491 DOI: 10.1111/bjh.16626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
69 Arese V, Murabito P, Ribero S, Panzone M, Tonella L, Fierro MT, Papini M, Quaglino P. Autoimmune connective tissue diseases and pregnancy. G Ital Dermatol Venereol 2019;154:263-76. [PMID: 30650958 DOI: 10.23736/S0392-0488.18.06252-1] [Reference Citation Analysis]
70 Burwick RM, Velásquez JA, Valencia CM, Gutiérrez-marín J, Edna-estrada F, Silva JL, Trujillo-otálvaro J, Vargas-rodríguez J, Bernal Y, Quintero A, Rincón M, Tolosa JE. Terminal Complement Activation in Preeclampsia. Obstetrics & Gynecology 2018;132:1477-85. [DOI: 10.1097/aog.0000000000002980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
71 Malinowski AK. Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras? Br J Haematol 2020;190:306-8. [PMID: 32342505 DOI: 10.1111/bjh.16694] [Reference Citation Analysis]
72 Liszewski MK, Atkinson JP. Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections. Curr Opin Immunol 2021;72:126-34. [PMID: 34004375 DOI: 10.1016/j.coi.2021.04.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Velásquez JA, Burwick RM, Hersh AR, Silva JL, Lenis V, Bernal Y, Vargas J, Valencia C, Gutiérrez JH, Edna F, Trujillo J, Rincón M, Alvarez MI, Tolosa JE. Plasma CD59 concentrations are increased in preeclampsia with severe features and correlate with laboratory measures of end-organ injury. Pregnancy Hypertens 2020;22:204-9. [PMID: 33091682 DOI: 10.1016/j.preghy.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Fakhouri F, Vercel C, Frémeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol 2012;7:2100-6. [PMID: 22879435 DOI: 10.2215/CJN.13121211] [Cited by in Crossref: 89] [Cited by in F6Publishing: 30] [Article Influence: 8.9] [Reference Citation Analysis]
75 Scully M. Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy. Hematology Am Soc Hematol Educ Program 2017;2017:651-9. [PMID: 29222317 DOI: 10.1182/asheducation-2017.1.651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
76 Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, Seppänen MRJ, Sullivan KE, Jolles S. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol 2020;40:576-91. [PMID: 32064578 DOI: 10.1007/s10875-020-00754-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
77 Bazzan M, Todros T, Tedeschi S, Ardissino G, Cardaropoli S, Stella S, Montaruli B, Marchese C, Roccatello D, Cugno M. Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome. Thromb Res 2020;196:167-74. [PMID: 32890900 DOI: 10.1016/j.thromres.2020.08.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Burwick RM, Feinberg BB. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Am J Obstet Gynecol 2020:S0002-9378(20)31129-7. [PMID: 32986992 DOI: 10.1016/j.ajog.2020.09.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Zeng S, Han M, Jiang M, Liu F, Hu Y, Long Y, Zhu C, Zeng F, Gan Q, Ye W, Fu W, Yang H. Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin. Reprod Biol Endocrinol 2021;19:56. [PMID: 33874952 DOI: 10.1186/s12958-021-00742-z] [Reference Citation Analysis]
80 Cataland SR, Yang S, Wu HM. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies. Br J Haematol 2012;157:501-3. [PMID: 22296585 DOI: 10.1111/j.1365-2141.2012.09032.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
81 Zhang Y, Jin S. Mitigating placental injuries through up-regulating DAF in experimental APS mice: new mechanism of progesterone. Clin Exp Immunol 2019;197:376-86. [PMID: 31091357 DOI: 10.1111/cei.13313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Jim B, Garovic VD. Acute Kidney Injury in Pregnancy. Semin Nephrol 2017;37:378-85. [PMID: 28711077 DOI: 10.1016/j.semnephrol.2017.05.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 11.8] [Reference Citation Analysis]
83 Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, Hisanaga S, Hiwa R, Nakamura F, Tomomori M, Miyagawa S, Fujimaru R, Yamada H, Sawai T, Ikeda Y, Iwata N, Uemura O, Matsukuma E, Aizawa Y, Harada H, Wada H, Ishikawa E, Ashida A, Nangaku M, Miyata T, Fujimura Y. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Molecular Immunology 2013;54:238-46. [DOI: 10.1016/j.molimm.2012.12.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
84 Teirilä L, Heikkinen-Eloranta J, Kotimaa J, Meri S, Lokki AI. Regulation of the complement system and immunological tolerance in pregnancy. Semin Immunol 2019;45:101337. [PMID: 31757607 DOI: 10.1016/j.smim.2019.101337] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
85 Acharya A. Management of Acute Kidney Injury in Pregnancy for the Obstetrician. Obstetrics and Gynecology Clinics of North America 2016;43:747-65. [DOI: 10.1016/j.ogc.2016.07.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
86 Oku K, Amengual O, Atsumi T. Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome: PATHOPHYSIOLOGY OF APS. European Journal of Clinical Investigation 2012;42:1126-35. [DOI: 10.1111/j.1365-2362.2012.02697.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
87 Kościelska-Kasprzak K, Bartoszek D, Myszka M, Zabińska M, Klinger M. The complement cascade and renal disease. Arch Immunol Ther Exp (Warsz) 2014;62:47-57. [PMID: 24030732 DOI: 10.1007/s00005-013-0254-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
88 Lateef A, Petri M. Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol. 2012;8:710-718. [PMID: 22907290 DOI: 10.1038/nrrheum.2012.133] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
89 Lynch AM, Wagner BD, Giclas PC, West NA, Gibbs RS, Holers VM. The Relationship of Longitudinal Levels of Complement Bb During Pregnancy with Preeclampsia. Am J Reprod Immunol 2016;75:104-11. [PMID: 26510395 DOI: 10.1111/aji.12439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
90 Buurma A, Cohen D, Veraar K, Schonkeren D, Claas FH, Bruijn JA, Bloemenkamp KW, Baelde HJ. Preeclampsia is characterized by placental complement dysregulation. Hypertension. 2012;60:1332-1337. [PMID: 23006730 DOI: 10.1161/hypertensionaha.112.194324] [Cited by in Crossref: 86] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
91 Schramm EC, Staten NR, Zhang Z, Bruce SS, Kellner C, Atkinson JP, Kyttaris VC, Tsokos GC, Petri M, Sander Connolly E, Olson PK. A quantitative lateral flow assay to detect complement activation in blood. Anal Biochem 2015;477:78-85. [PMID: 25660530 DOI: 10.1016/j.ab.2015.01.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
92 Liszewski MK, Atkinson JP. Too Much of a Good Thing at the Site of Tissue Injury: The Instructive Example of the Complement System Predisposing to Thrombotic Microangiopathy. Hematology 2011;2011:9-14. [DOI: 10.1182/asheducation-2011.1.9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
93 Lo Turco EG, Cordeiro FB, de Carvalho Lopes PH, Gozzo FC, Pilau EJ, Soler TB, da Silva BF, Del Giudice PT, Bertolla RP, Fraietta R, Cedenho AP. Proteomic analysis of follicular fluid from women with and without endometriosis: New therapeutic targets and biomarkers: PROTEOMICS IN FOLLICULAR FLUID. Mol Reprod Dev 2013;80:441-50. [DOI: 10.1002/mrd.22180] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
94 Girardi G, Lingo JJ, Fleming SD, Regal JF. Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond. Front Immunol 2020;11:1681. [PMID: 32849586 DOI: 10.3389/fimmu.2020.01681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
95 Ruffatti A, Favaro M, Calligaro A, Zambon A, Del Ross T. Management of pregnant women with antiphospholipid antibodies. Expert Review of Clinical Immunology 2019;15:347-58. [DOI: 10.1080/1744666x.2019.1565995] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
96 Amari Chinchilla K, Vijayan M, Taveras Garcia B, Jim B. Complement-Mediated Disorders in Pregnancy. Adv Chronic Kidney Dis 2020;27:155-64. [PMID: 32553248 DOI: 10.1053/j.ackd.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Baines AC, Brodsky RA. Complementopathies. Blood Rev 2017;31:213-23. [PMID: 28215731 DOI: 10.1016/j.blre.2017.02.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
98 Breen KA, Seed P, Parmar K, Moore GW, Stuart-smith SE, Hunt BJ. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome. Thromb Haemost 2017;107:423-9. [DOI: 10.1160/th11-08-0554] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 12.6] [Reference Citation Analysis]
99 McDonald CR, Tran V, Kain KC. Complement Activation in Placental Malaria. Front Microbiol 2015;6:1460. [PMID: 26733992 DOI: 10.3389/fmicb.2015.01460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
100 Gavriilaki E, Anagnostopoulos A, Mastellos DC. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics. Front Immunol 2019;10:337. [PMID: 30891033 DOI: 10.3389/fimmu.2019.00337] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 11.7] [Reference Citation Analysis]
101 Denny KJ, Coulthard LG, Finnell RH, Callaway LK, Taylor SM, Woodruff TM. Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia. Journal of Reproductive Immunology 2013;97:211-6. [DOI: 10.1016/j.jri.2012.11.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
102 Gerardi MC, Fernandes MA, Tincani A, Andreoli L. Obstetric Anti-phospholipid Syndrome: State of the Art. Curr Rheumatol Rep 2018;20:59. [PMID: 30105597 DOI: 10.1007/s11926-018-0772-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
103 Lokki AI, Heikkinen-Eloranta J. Pregnancy induced TMA in severe preeclampsia results from complement-mediated thromboinflammation. Hum Immunol 2021;82:371-8. [PMID: 33820656 DOI: 10.1016/j.humimm.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Yamaguchi M, Hori M, Hiroshi N, Maruyama S. Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab. Thromb Res 2017;151:79-81. [PMID: 28167400 DOI: 10.1016/j.thromres.2017.01.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Blasco M, Guillén E, Quintana LF, Garcia-Herrera A, Piñeiro G, Poch E, Carreras E, Campistol JM, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. Clin Kidney J 2021;14:1055-66. [PMID: 33841853 DOI: 10.1093/ckj/sfaa195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet 2017;390:681-96. [PMID: 28242109 DOI: 10.1016/S0140-6736(17)30062-4] [Cited by in Crossref: 202] [Cited by in F6Publishing: 108] [Article Influence: 40.4] [Reference Citation Analysis]
107 Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Ann Rheum Dis 2018;77:549-55. [PMID: 29371202 DOI: 10.1136/annrheumdis-2017-212224] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 15.5] [Reference Citation Analysis]
108 Ernst LM, Rand CM, Bao R, Andrade J, Linn RL, Minturn L, Zhang C, Kang W, Weese-Mayer DE. Stillbirth: Genome-wide copy number variation profiling in archived placental umbilical cord samples with pathologic and clinical correlation. Placenta 2015;36:783-9. [PMID: 26094028 DOI: 10.1016/j.placenta.2015.04.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
109 Kronbichler A, Frank R, Kirschfink M, Szilágyi Á, Csuka D, Prohászka Z, Schratzberger P, Lhotta K, Mayer G. Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report. Medicine (Baltimore) 2014;93:e143. [PMID: 25474424 DOI: 10.1097/MD.0000000000000143] [Cited by in Crossref: 71] [Cited by in F6Publishing: 29] [Article Influence: 10.1] [Reference Citation Analysis]
110 Kaneko K, Ozawa N, Murashima A. Obstetric anti-phospholipid syndrome: from pathogenesis to treatment. Immunol Med 2021;:1-15. [PMID: 34470570 DOI: 10.1080/25785826.2021.1969116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Kaye R, Chandra S, Sheth J, Boon CJF, Sivaprasad S, Lotery A. Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res 2020;79:100865. [PMID: 32407978 DOI: 10.1016/j.preteyeres.2020.100865] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
112 Salmon J. PROMISSE: progress in understanding pregnancy complications in patients with SLE. Arthritis Res Ther 2012;14. [DOI: 10.1186/ar3973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 West EE, Kunz N, Kemper C. Complement and human T cell metabolism: Location, location, location. Immunol Rev 2020;295:68-81. [PMID: 32166778 DOI: 10.1111/imr.12852] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
114 Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: Differential diagnosis. Pregnancy Hypertens 2018;12:29-34. [PMID: 29674195 DOI: 10.1016/j.preghy.2018.02.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
115 Burwick R, Feinberg B. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta 2013;34:201-3. [DOI: 10.1016/j.placenta.2012.11.014] [Cited by in Crossref: 127] [Cited by in F6Publishing: 105] [Article Influence: 14.1] [Reference Citation Analysis]
116 Tsai HM. Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update. Hematol Oncol Clin North Am 2013;27:565-84. [PMID: 23714312 DOI: 10.1016/j.hoc.2013.02.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
117 Wat JM, Audette MC, Kingdom JC. Molecular actions of heparin and their implications in preventing pre-eclampsia. J Thromb Haemost 2018. [PMID: 29877031 DOI: 10.1111/jth.14191] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
118 Lokki AI, Heikkinen-Eloranta JK, Laivuori H. The Immunogenetic Conundrum of Preeclampsia. Front Immunol 2018;9:2630. [PMID: 30483272 DOI: 10.3389/fimmu.2018.02630] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
119 Triebwasser MP, Wu X, Bertram P, Hourcade DE, Nelson DM, Atkinson JP. Timing and mechanism of conceptus demise in a complement regulatory membrane protein deficient mouse. Am J Reprod Immunol 2018;80:e12997. [PMID: 29924462 DOI: 10.1111/aji.12997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Hanouna G, Morel N, Le Thi Huong D, Josselin L, Vauthier-brouzes D, Saadoun D, Kettaneh A, Levesque K, Le Guern V, Goffinet F, Carbonne B, Amoura Z, Piette J, Nizard J, Costedoat-chalumeau N. Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases. Rheumatology 2013;52:1635-41. [DOI: 10.1093/rheumatology/ket167] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
121 Larosa M, Del Ross T, Calligaro A, Favaro M, Zanatta E, Iaccarino L, Doria A. Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus. Expert Rev Clin Immunol 2019;15:617-27. [PMID: 30933534 DOI: 10.1080/1744666X.2019.1601557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
122 Zhao L, Triche EW, Walsh KM, Bracken MB, Saftlas AF, Hoh J, Dewan AT. Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients. BMC Pregnancy Childbirth 2012;12:61. [PMID: 22748001 DOI: 10.1186/1471-2393-12-61] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
123 Fredi M, Gregorini G, Zatti S, Lojacono A, Tincani A. Identifying and managing lupus nephritis during pregnancy. Expert Opinion on Orphan Drugs 2016;4:1021-31. [DOI: 10.1080/21678707.2016.1228452] [Reference Citation Analysis]
124 Banadakoppa M, Pennington K, Balakrishnan M, Yallampalli C. Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth. PLoS One 2020;15:e0236968. [PMID: 32745140 DOI: 10.1371/journal.pone.0236968] [Reference Citation Analysis]
125 Neave L, Scully M. Microangiopathic Hemolytic Anemia in Pregnancy. Transfus Med Rev 2018;32:230-6. [PMID: 30177429 DOI: 10.1016/j.tmrv.2018.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
126 Ferrer-Oliveras R, Mendoza M, Capote S, Pratcorona L, Esteve-Valverde E, Cabero-Roura L, Alijotas-Reig J. Immunological and physiopathological approach of COVID-19 in pregnancy. Arch Gynecol Obstet 2021;304:39-57. [PMID: 33945026 DOI: 10.1007/s00404-021-06061-3] [Reference Citation Analysis]
127 Bounds KR, Newell-Rogers MK, Mitchell BM. Four Pathways Involving Innate Immunity in the Pathogenesis of Preeclampsia. Front Cardiovasc Med 2015;2:20. [PMID: 26664892 DOI: 10.3389/fcvm.2015.00020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
128 Mulla MJ, Weel IC, Potter JA, Gysler SM, Salmon JE, Peraçoli MTS, Rothlin CV, Chamley LW, Abrahams VM. Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators. Arthritis Rheumatol 2018;70:891-902. [PMID: 29342502 DOI: 10.1002/art.40416] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
129 Kerr H, Richards A. Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome. Immunobiology 2012;217:195-203. [PMID: 21855165 DOI: 10.1016/j.imbio.2011.07.028] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
130 Bulla R, Bossi F, Tedesco F. The complement system at the embryo implantation site: friend or foe? Front Immunol 2012;3:55. [PMID: 22566936 DOI: 10.3389/fimmu.2012.00055] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
131 Perricone C, de Carolis C, Perricone R. Pregnancy and autoimmunity: A common problem. Best Practice & Research Clinical Rheumatology 2012;26:47-60. [DOI: 10.1016/j.berh.2012.01.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
132 Gelber SE, Brent E, Redecha P, Perino G, Tomlinson S, Davisson RL, Salmon JE. Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency. J Immunol 2015;195:1129-38. [PMID: 26071558 DOI: 10.4049/jimmunol.1402220] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
133 Banadakoppa M, Vidaeff AC, Yallampalli U, Ramin SM, Belfort MA, Yallampalli C. Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia. Dis Markers 2015;2015:263109. [PMID: 26556948 DOI: 10.1155/2015/263109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
134 Wang S, Huang Q, Zhong M, Yin Q. AOPPs (advanced oxidation protein products) promote apoptosis in trophoblastic cells through interference with NADPH oxidase signaling: implications for preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 2014;28:1747-55. [DOI: 10.3109/14767058.2014.969231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
135 Barbour T, Johnson S, Cohney S, Hughes P. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012;27:2673-2685. [PMID: 22802583 DOI: 10.1093/ndt/gfs279] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 12.1] [Reference Citation Analysis]
136 Khan R, Maduray K, Moodley J, Naicker T. Activation of CD35 and CD55 in HIV associated normal and pre-eclamptic pregnant women. Eur J Obstet Gynecol Reprod Biol 2016;204:51-6. [PMID: 27521598 DOI: 10.1016/j.ejogrb.2016.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
137 Timmermans SAMEG, van Paassen P. The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation. J Clin Med 2021;10:3034. [PMID: 34300201 DOI: 10.3390/jcm10143034] [Reference Citation Analysis]
138 Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, Zhao MH, Bruijn JA, Bajema IM. Pros and cons for C4d as a biomarker. Kidney Int. 2012;81:628-639. [PMID: 22297669 DOI: 10.1038/ki.2011.497] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 11.7] [Reference Citation Analysis]
139 Elliott SE, Parchim NF, Liu C, Xia Y, Kellems RE, Soffici AR, Daugherty PS. Characterization of antibody specificities associated with preeclampsia. Hypertension 2014;63:1086-93. [PMID: 24446060 DOI: 10.1161/HYPERTENSIONAHA.113.02362] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
140 Chen S, Li Z, He Y, Chen Q. Dysregulation of complement system in HELLP syndrome. Hypertens Pregnancy 2021;40:303-11. [PMID: 34697959 DOI: 10.1080/10641955.2021.1983593] [Reference Citation Analysis]
141 Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, Tincani A. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. Journal of Autoimmunity 2012;38:J197-208. [DOI: 10.1016/j.jaut.2011.11.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
142 Fakhouri F, Frémeaux-Bacchi V. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat Rev Nephrol 2021;17:543-53. [PMID: 33953366 DOI: 10.1038/s41581-021-00424-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Gris J, Bouvier S. Antiphospholipid syndrome: Looking for a refocusing. Thrombosis Research 2013;131:S28-31. [DOI: 10.1016/s0049-3848(13)70016-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
144 Rambaldi MP, Weiner E, Mecacci F, Bar J, Petraglia F. Immunomodulation and preeclampsia. Best Practice & Research Clinical Obstetrics & Gynaecology 2019;60:87-96. [DOI: 10.1016/j.bpobgyn.2019.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
145 Velickovic I, Dalloul M, Wong KA, Bakare O, Schweis F, Garala M, Alam A, Medranda G, Lekovic J, Shuaib W, Tedjasukmana A, Little P, Hanono D, Wijetilaka R, Weedon J, Lin J, Toledano Rd, Zhang M. Complement factor B activation in patients with preeclampsia. J Reprod Immunol 2015;109:94-100. [PMID: 25604034 DOI: 10.1016/j.jri.2014.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
146 Nikolajeva O, Worth A, Hague R, Martinez-Alier N, Smart J, Adams S, Davies EG, Gaspar HB. Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome. J Clin Immunol 2015;35:366-72. [PMID: 25875700 DOI: 10.1007/s10875-015-0158-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
147 Vijayan M, Avendano M, Chinchilla KA, Jim B. Acute kidney injury in pregnancy. Curr Opin Crit Care 2019;25:580-90. [PMID: 31524717 DOI: 10.1097/MCC.0000000000000656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Abu-Raya B, Michalski C, Sadarangani M, Lavoie PM. Maternal Immunological Adaptation During Normal Pregnancy. Front Immunol 2020;11:575197. [PMID: 33133091 DOI: 10.3389/fimmu.2020.575197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
149 Dines V, Kattah A. Hypertensive Disorders of Pregnancy. Adv Chronic Kidney Dis 2020;27:531-9. [PMID: 33328070 DOI: 10.1053/j.ackd.2020.05.006] [Reference Citation Analysis]
150 Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick RM. Urinary Excretion of C5b-9 is Associated With the Anti-Angiogenic State in Severe Preeclampsia. Am J Reprod Immunol 2015;73:437-44. [DOI: 10.1111/aji.12349] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
151 Banadakoppa M, Chauhan MS, Havemann D, Balakrishnan M, Dominic JS, Yallampalli C. Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta. Clin Exp Immunol 2014;177:743-9. [PMID: 24802103 DOI: 10.1111/cei.12371] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
152 Ergin RN. Pregnancy-associated systemic lupus erythematosus. Proc (Bayl Univ Med Cent) 2014;27:221-2. [PMID: 24982567 DOI: 10.1080/08998280.2014.11929116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, Lämmle B, Matsumoto M, Pavenski K, Sadler E, Sarode R, Wu H; International Working Group for Thrombotic Thrombocytopenic Purpura. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 2017;15:312-22. [PMID: 27868334 DOI: 10.1111/jth.13571] [Cited by in Crossref: 190] [Cited by in F6Publishing: 171] [Article Influence: 38.0] [Reference Citation Analysis]
154 Saenz-de-juano MD, Marco-jimenez F, Schmaltz-panneau B, Jimenez-trigos E, Viudes-de-castro MP, Peñaranda DS, Jouneau L, Lecardonnel J, Lavara R, Naturil-alfonso C, Duranthon V, Vicente JS. Vitrification alters rabbit foetal placenta at transcriptomic and proteomic level. REPRODUCTION 2014;147:789-801. [DOI: 10.1530/rep-14-0019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
155 Lateef A, Petri M. Systemic Lupus Erythematosus and Pregnancy. Rheum Dis Clin North Am 2017;43:215-26. [PMID: 28390564 DOI: 10.1016/j.rdc.2016.12.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
156 Tsai H. A Mechanistic Approach to the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome. Transfusion Medicine Reviews 2014;28:187-97. [DOI: 10.1016/j.tmrv.2014.08.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
157 Guettrot-imbert G, Le Guern V, Morel N, Vauthier D, Tsatsaris V, Pannier E, Piette J, Costedoat-chalumeau N. Lupus systémique et syndrome des antiphospholipides : comment prendre en charge la grossesse ? La Revue de Médecine Interne 2015;36:173-81. [DOI: 10.1016/j.revmed.2014.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
158 Cataland SR, Wu HM. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome. Blood 2014;123:2478-84. [PMID: 24599547 DOI: 10.1182/blood-2013-11-516237] [Cited by in Crossref: 86] [Cited by in F6Publishing: 61] [Article Influence: 10.8] [Reference Citation Analysis]
159 Schraufstatter IU, Khaldoyanidi SK, DiScipio RG. Complement activation in the context of stem cells and tissue repair. World J Stem Cells 2015; 7(8): 1090-1108 [PMID: 26435769 DOI: 10.4252/wjsc.v7.i8.1090] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
160 Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011;6:60. [PMID: 21902819 DOI: 10.1186/1750-1172-6-60] [Cited by in Crossref: 375] [Cited by in F6Publishing: 304] [Article Influence: 34.1] [Reference Citation Analysis]
161 Huang J, Qin H, Yang Y, Chen X, Zhang J, Laird S, Wang CC, Chan TF, Li TC. A comparison of transcriptomic profiles in endometrium during window of implantation between women with unexplained recurrent implantation failure and recurrent miscarriage. Reproduction 2017;153:749-58. [PMID: 28283674 DOI: 10.1530/REP-16-0574] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 7.6] [Reference Citation Analysis]
162 Radin M, Cecchi I, Schreiber K, Rubini E, Roccatello D, Cuadrado MJ, Sciascia S. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. Semin Arthritis Rheum 2020;50:553-6. [PMID: 32089355 DOI: 10.1016/j.semarthrit.2020.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
163 Brown CM, Garovic VD. Mechanisms and management of hypertension in pregnant women. Curr Hypertens Rep 2011;13:338-46. [PMID: 21656283 DOI: 10.1007/s11906-011-0214-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
164 Román E, Mendizábal S, Jarque I, de la Rubia J, Sempere A, Morales E, Praga M, Ávila A, Górriz JL. Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option. Nefrología (English Edition) 2017;37:478-91. [DOI: 10.1016/j.nefroe.2017.08.001] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
165 Zhao C, Zhao J, Huang Y, Wang Z, Wang H, Zhang H, Xu H, Yang N. New-onset systemic lupus erythematosus during pregnancy. Clin Rheumatol 2013;32:815-22. [PMID: 23358829 DOI: 10.1007/s10067-013-2180-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
166 Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic V. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus 2012;21:534-41. [PMID: 22311940 DOI: 10.1177/0961203311434939] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
167 Pantham P, Abrahams VM, Chamley LW. The role of anti-phospholipid antibodies in autoimmune reproductive failure. Reproduction 2016;151:R79-90. [DOI: 10.1530/rep-15-0545] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
168 Yonekura Collier AR, Zsengeller Z, Pernicone E, Salahuddin S, Khankin EV, Karumanchi SA. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia. Hypertens Pregnancy 2019;38:193-9. [PMID: 31291799 DOI: 10.1080/10641955.2019.1640725] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
169 Lokki AI, Teirilä L, Triebwasser M, Daly E, Bhattacharjee A, Uotila L, Llort Asens M, Kurki MI, Perola M, Auro K, Salmon JE, Daly M, Atkinson JP, Laivuori H, Fagerholm S, Meri S; Finnpec. Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study. BJOG 2021;128:1282-91. [PMID: 33539617 DOI: 10.1111/1471-0528.16660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Kattah A. Preeclampsia and Kidney Disease: Deciphering Cause and Effect. Curr Hypertens Rep 2020;22:91. [PMID: 32926258 DOI: 10.1007/s11906-020-01099-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EKS, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F. Hemolytic Uremic Syndrome in Pregnancy and Postpartum. Clin J Am Soc Nephrol 2017;12:1237-47. [PMID: 28596415 DOI: 10.2215/CJN.00280117] [Cited by in Crossref: 86] [Cited by in F6Publishing: 37] [Article Influence: 17.2] [Reference Citation Analysis]
172 Meuleman T, Cohen D, Swings GM, Veraar K, Claas FH, Bloemenkamp KW. Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage. Journal of Reproductive Immunology 2016;113:54-60. [DOI: 10.1016/j.jri.2015.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Mulla MJ, Salmon JE, Chamley LW, Brosens JJ, Boeras CM, Kavathas PB, Abrahams VM. A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast. PLoS One 2013;8:e65237. [PMID: 23762324 DOI: 10.1371/journal.pone.0065237] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
174 Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report. J Med Case Rep 2015;9:92. [PMID: 25925370 DOI: 10.1186/s13256-015-0575-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
175 Fakhouri F. Pregnancy-related thrombotic microangiopathies: Clues from complement biology. Transfus Apher Sci 2016;54:199-202. [PMID: 27158062 DOI: 10.1016/j.transci.2016.04.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
176 Schneider J, Walz G, Neumann-Haefelin E. [Hypertensive Disorders in Pregnancy]. Dtsch Med Wochenschr 2021;146:279-86. [PMID: 33592664 DOI: 10.1055/a-1233-7685] [Reference Citation Analysis]
177 Wong EKS, Kavanagh D. Diseases of complement dysregulation-an overview. Semin Immunopathol 2018;40:49-64. [PMID: 29327071 DOI: 10.1007/s00281-017-0663-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
178 Choudhury M, Friedman JE. Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens. 2012;34:334-341. [PMID: 22468840 DOI: 10.3109/10641963.2011.649931] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
179 Park HJ, Atkinson JP. Autoimmunity: homeostasis of innate immunity gone awry. J Clin Immunol 2012;32:1148-52. [PMID: 23054347 DOI: 10.1007/s10875-012-9815-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
180 Stefanovic V. The Extended Use of Eculizumab in Pregnancy and Complement Activation⁻Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now? J Clin Med 2019;8:E407. [PMID: 30909646 DOI: 10.3390/jcm8030407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
181 Girardi G. Complement activation, a threat to pregnancy. Semin Immunopathol 2018;40:103-11. [PMID: 28900713 DOI: 10.1007/s00281-017-0645-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
182 Fakhouri F, Scully M, Provôt F, Blasco M, Coppo P, Noris M, Paizis K, Kavanagh D, Pène F, Quezada S, Hertig A, Kissling S, O'Brien P, Delmas Y, Alberio L, Winer N, Veyradier A, Cataland S, Frémeaux-Bacchi V, Loirat C, Remuzzi G, Tsatsaris V. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood 2020;136:2103-17. [PMID: 32808006 DOI: 10.1182/blood.2020005221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
183 Lim W. Complement and the antiphospholipid syndrome. Curr Opin Hematol 2011;18:361-5. [PMID: 21730831 DOI: 10.1097/MOH.0b013e3283497f3e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]